ATS 2018 International Conference - Mobile

Evaluating the Impact and Benefits of Once Daily Fluticasone Furoate/Vilanterol (FF/VI) in Asthma and Chronic Obstructive Pulmonary Disease (COPD) [Board No. P18]

Location: Board no. P18

Session Type: Thematic Poster Session

Tuesday

May

22

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Lisa Bradshaw

PhD
NHS, Sheffield & Health and Safety Laboratory

Henrik Svedsater

PhD
GSK

Helen Doll

DPhil
ICON plc

Gail Miles

MSc
NHS

Magdalena Vanya

PhD
ICON PLC

Jake Macey

MSc
ICON plc

View Abstract

Evaluating the Impact and Benefits of Once Daily Fluticasone Furoate/Vilanterol (FF/VI) in Asthma and Chronic Obstructive Pulmonary Disease (COPD)

Parent Sessions

C37 - OPTIMIZING ASTHMA CARE ACROSS DIVERSE PATIENTS...
05-22-2018 9:15 AM - 4:15 PM